Effects of hyaluronic acid conjugation on anti-TNF-α inhibition of inflammation in burns

Journal of Biomedical Materials Research - Part A

Volumn 102, Issue 5, 2014, Pages 1527-1536

  Friedrich, Emily E ^a   Sun, Liang Tso ^a   Natesan, Shanmugasundaram ^b   Zamora, David O ^b   Christy, Robert J ^b   Washburn, Newell R ^a,c,d  

^a CARNEGIE MELLON UNIVERSITY   (United States)

^b U S ARMY   (United States)

^c CARNEGIE MELLON UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

burn wound inflammation; hyaluronic acid; TNF alpha; wound healing

Indexed keywords

BIOLOGICAL MATERIALS; MACROPHAGES; ORGANIC ACIDS; PATHOLOGY;

BURN WOUND INFLAMMATION; HIGH MOLECULAR WEIGHT; INFLAMMATORY RESPONSE; MACROPHAGE INFILTRATIONS; TNF-ALPHA; TOPICAL APPLICATION; TRANSPORT MODELING; WOUND HEALING;

HYALURONIC ACID;

HYALURONIC ACID; INTERLEUKIN 1BETA; POLYURETHAN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; VIMENTIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; BURN; CONTROLLED STUDY; GRANULATION TISSUE; HISTOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; NONHUMAN; RAT; WOUND HEALING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; CELL COUNT; COMPLICATION; DRUG EFFECTS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; STAINING;

ANIMALS; BURNS; CELL COUNT; HYALURONIC ACID; INFLAMMATION; INTERLEUKIN-1BETA; MACROPHAGES; MODELS, BIOLOGICAL; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; TUMOR NECROSIS FACTOR-ALPHA; VIMENTIN;

EID: 84897109224     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34829     Document Type: Article

References (38)

1. Sun LT, Buchholz KS, Lotze MT, Washburn NR,. Cytokine binding by polysaccharide-antibody conjugates. Mol Pharm 2010; 7: 1769-1777.
2. Sun LT, Bencherif SA, Gilbert TW, Farkas AM, Lotze MT, Washburn NR,. Biological activities of cytokine-neutralizing hyaluronic acid-antibody conjugates. Wound Repair Regen 2010; 18: 302-310.
3. Sun LT, Bencherif SA, Gilbert TW, Lotze MT, Washburn NR,. Design principles for cytokine-neutralizing gels: Cross-linking effects. Acta Biomater 2010; 6: 4708-4715.
4. Jackson DM,. The diagnosis of the depth of burning. Br J Surg 1953; 40: 588-596.
5. Johnson RM, Richard R,. Partial-thickness burns: Identification and management. Adv Skin Wound Care 2003; 16: 178-187; quiz 88-9.
6. Singh V, Devgan L, Bhat S, Milner SM,. The pathogenesis of burn wound conversion. Ann Plast Surg 2007; 59: 109-115. (Pubitemid 46987993)
7. Shupp JW, Nasabzadeh TJ, Rosenthal DS, Jordan MH, Fidler P, Jeng JC,. A review of the local pathophysiologic bases of burn wound progression. J Burn Care Res 2010; 31: 849-873.
8. Arturson G,. Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995. Burns 1996; 22: 255-274.
9. Akira S, Takeda K,. Toll-like receptor signalling. Nat Rev Immunol 2004; 4: 499-511. (Pubitemid 38931765)
10. Beutler B, Cerami A,. The biology of cachectin/TNF-A primary mediator of the host response. Annu Rev Immunol 1989; 7: 625-655. (Pubitemid 19138027)
11. Schwacha MG, Thobe BM, Daniel T, Hubbard WJ,. Impact of thermal injury on wound infiltration and the dermal inflammatory response. J Surg Res 2010; 158: 112-120.
12. Zhang C, Wu J, Xu X, Potter BJ, Gao X,. Direct relationship between levels of TNF-alpha expression and endothelial dysfunction in reperfusion injury. Basic Res Cardiol 2010; 105: 453-464.
13. Proudman SM, Cleland LG, Mayrhofer G,. Effects of tumor necrosis factor-alpha, interleukin 1beta, and activated peripheral blood mononuclear cells on the expression of adhesion molecules and recruitment of leukocytes in rheumatoid synovial xenografts in SCID mice. J Rheumatol 1999; 26: 1877-1889. (Pubitemid 30007053)
14. Edwards SW, Derouet M, Howse M, Moots RJ,. Regulation of neutrophil apoptosis by Mcl-1. Biochem Soc Trans 2004; 32 (Pt 3): 489-492. (Pubitemid 38813545)
15. Piguet PF, Grau GE, Vassalli P,. Subcutaneous perfusion of tumor necrosis factor induces local proliferation of fibroblasts, capillaries, and epidermal cells, or massive tissue necrosis. Am J Pathol 1990; 136: 103-110. (Pubitemid 20034957)
16. Finnerty CC, Przkora R, Herndon DN, Jeschke MG,. Cytokine expression profile over time in burned mice. Cytokine 2009; 45: 20-25.
17. Finnerty CC, Herndon DN, Przkora R, Pereira CT, Oliveira HM, Queiroz DM, Rocha AM, Jeschke MG,. Cytokine expression profile over time in severely burned pediatric patients. Shock 2006; 26: 13-19. (Pubitemid 44297000)
18. Sfikakis PP,. The first decade of biologic TNF antagonists in clinical practice: Lessons learned, unresolved issues and future directions. Curr Dir Autoimmun 2010; 11: 180-210.
19. Gupta AK, Skinner AR,. A review of the use of infliximab to manage cutaneous dermatoses. J Cutan Med Surg 2004; 8: 77-89. (Pubitemid 38781360)
20. Scheinfeld N,. A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 2004; 15: 280-294. (Pubitemid 39423287)
21. Voigt J, Driver VR,. Hyaluronic acid derivatives and their healing effect on burns, epithelial surgical wounds, and chronic wounds: A systematic review and meta-analysis of randomized controlled trials. Wound Repair Regen 2012; 20: 317-331.
22. Salbach J, Rachner TD, Rauner M, Hempel U, Anderegg U, Franz S, Simon JC, Hofbauer LC,. Regenerative potential of glycosaminoglycans for skin and bone. J Mol Med (Berl) 2012; 90: 625-635.
23. Sun LT, Friedrich E, Heuslein JL, Pferdehirt RE, Dangelo NM, Natesan S, Christy RJ, Washburn NR,. Reduction of burn progression with topical delivery of (antitumor necrosis factor-alpha)-hyaluronic acid conjugates. Wound Repair Regen 2012; 20: 563-572.
24. Chang KC, Ma H, Liao WC, Lee CK, Lin CY, Chen CC,. The optimal time for early burn wound excision to reduce pro-inflammatory cytokine production in a murine burn injury model. Burns 2010; 36: 1059-1066.
25. Nanney LB, Wenczak BA, Lynch JB,. Progressive burn injury documented with vimentin immunostaining. J Burn Care Rehabil 1996; 17: 191-198. (Pubitemid 26160947)
26. Gauglitz GG, Song J, Herndon DN, Finnerty CC, Boehning D, Barral JM, Jeschke MG,. Characterization of the inflammatory response during acute and post-acute phases after severe burn. Shock 2008; 30: 503-507.
27. Sakallioglu AE, Basaran O, Karakayali H, Ozdemir BH, Yucel M, Arat Z, Haberal M,. Interactions of systemic immune response and local wound healing in different burn depths: An experimental study on rats. J Burn Care Res 2006; 27: 357-366. (Pubitemid 43970304)
28. Clauss MA, Jain RK,. Interstitial transport of rabbit and sheep antibodies in normal and neoplastic tissues. Cancer Res 1990; 50: 3487-3492. (Pubitemid 20194084)
29. Cevc G, Vierl U,. Spatial distribution of cutaneous microvasculature and local drug clearance after drug application on the skin. J Controlled Release 2007; 118: 18-26. (Pubitemid 46283095)
30. Kaminski T, Siebrasse JP, Gieselmann V, Kubitscheck U, Kappler J,. Imaging and tracking of single hyaluronan molecules diffusing in solution. Glycoconj J 2008; 25: 555-560.
31. Laurent UB, Fraser JR, Laurent TC,. An experimental technique to study the turnover of concentrated hyaluronan in the anterior chamber of the rabbit. Exp Eye Res 1988; 46: 49-58.
32. Cheong R, Bergmann A, Werner SL, Regal J, Hoffmann A, Levchenko A,. Transient IkappaB kinase activity mediates temporal NF-kappaB dynamics in response to a wide range of tumor necrosis factor-alpha doses. J Biol Chem 2006; 281: 2945-2950. (Pubitemid 43845761)
33. Francis K, Palsson BO,. Effective intercellular communication distances are determined by the relative time constants for cyto/chemokine secretion and diffusion. Proc Natl Acad Sci USA 1997; 94: 12258-12262. (Pubitemid 27492515)
34. Daley JM, Brancato SK, Thomay AA, Reichner JS, Albina JE,. The phenotype of murine wound macrophages. J Leukoc Biol 2010; 87: 59-67.
35. Arend WP,. The mode of action of cytokine inhibitors. J Rheumatol Suppl 2002; 65: 16-21. (Pubitemid 34988677)
36. Duffield JS,. The inflammatory macrophage: A story of Jekyll and Hyde. Clin Sci (Lond) 2003; 104: 27-38. (Pubitemid 36249921)
37. Juniantito V, Izawa T, Yamamoto E, Murai F, Kuwamura M, Yamate J,. Heterogeneity of macrophage populations and expression of Galectin-3 in cutaneous wound healing in rats. J Comp Pathol 2011; 145: 378-389.
38. Voinchet V, Vasseur P, Kern J,. Efficacy and safety of hyaluronic acid in the management of acute wounds. Am J Clin Dermatol 2006; 7: 353-357. (Pubitemid 46998569)